A 42-year-old woman admitted for acute pancreatitis 5 days ago now has oliguria (urine output 200 mL/day) and rising serum creatinine (2.8 mg/dL, baseline 0.9 mg/dL). Urinalysis shows granular casts and mild proteinuria (0.8 g/day). Serum myoglobin is elevated at 1200 ng/mL (normal < 100), and urine myoglobin is positive. Serum potassium is 5.2 mEq/L, and phosphate is 6.8 mg/dL. Urine pH is 5.2. The patient is euvolemic on clinical examination. What is the most appropriate next step?

Explanation

## Clinical Context This patient has **rhabdomyolysis-induced acute tubular necrosis (ATN)** complicating acute pancreatitis. The diagnostic clues are: - **Elevated serum myoglobin (1200 ng/mL)** and **positive urine myoglobin** - **Granular (muddy brown) casts** — hallmark of ATN - **Acute rise in creatinine** with oliguria - **Hyperkalemia (5.2 mEq/L) and hyperphosphatemia (6.8 mg/dL)** — typical of rhabdo-ATN - **Acidic urine (pH 5.2)** — myoglobin precipitates in acidic urine, worsening tubular obstruction ## Pathophysiology of Rhabdomyolysis-Induced ATN **Key Point:** Myoglobin is a large protein that precipitates in acidic, concentrated urine, causing direct tubular obstruction and ischemic injury. The primary management goal is to **prevent myoglobin precipitation** through aggressive hydration and urine alkalinization. ### Mechanism of Myoglobin-Induced Renal Injury 1. **Tubular obstruction** — myoglobin casts block the tubular lumen 2. **Direct tubular toxicity** — myoglobin generates reactive oxygen species 3. **Ischemic injury** — volume depletion reduces renal perfusion 4. **Acidification worsens precipitation** — myoglobin is insoluble at pH < 6.8 ## Why Aggressive IV Fluids + Sodium Bicarbonate is Correct | Intervention | Mechanism | Target | |--------------|-----------|--------| | **Normal saline IV** | Restores intravascular volume, increases GFR, dilutes myoglobin | Urine output > 200 mL/hr | | **Sodium bicarbonate** | Alkalinizes urine to pH > 6.8, prevents myoglobin precipitation | Target urine pH 6.5–7.5 | | **Combination effect** | Volume + alkalinization = maximal myoglobin solubility | Prevents tubular obstruction | **High-Yield:** The goal in rhabdo-ATN is **urine output ≥ 200 mL/hr** and **urine pH ≥ 6.5**. This is more aggressive than standard AKI management because myoglobin precipitation is the primary pathology. ## Management Algorithm for Rhabdomyolysis-Induced ATN ```mermaid flowchart TD A["Rhabdomyolysis suspected<br/>(↑ CK, ↑ myoglobin, myoglobinuria)"]:::outcome --> B{"Euvolemic or<br/>hypovolemic?"}:::decision B -->|Hypovolemic| C["Aggressive NS bolus<br/>500 mL-1 L IV"]:::action B -->|Euvolemic| D["Maintenance fluids<br/>+ target UOP 200 mL/hr"]:::action C --> E["Add sodium bicarbonate<br/>to alkalinize urine"]:::action D --> E E --> F{"Urine pH > 6.5<br/>& UOP > 200 mL/hr?"}:::decision F -->|Yes| G["Continue fluids + bicarb<br/>Monitor K, PO4, Cr q6h"]:::action F -->|No| H["↑ IV rate & bicarb dose<br/>Recheck pH q2h"]:::action H --> I{"Response in 24 hrs?"}:::decision I -->|No| J["Consider dialysis<br/>if K > 6.5 or Cr > 8"]:::urgent I -->|Yes| G ``` ## Why Other Options Are Inappropriate ### Option 1: Immediate Hemodialysis - **K^+^ = 5.2 mEq/L** is only mildly elevated and not immediately life-threatening without ECG changes - **Dialysis removes fluid** and worsens renal perfusion in a patient with rhabdo-ATN - **Dialysis is reserved** for K^+^ > 6.5 with ECG changes, or if conservative measures fail after 24–48 hours - Premature dialysis increases mortality in rhabdo-ATN by preventing myoglobin clearance ### Option 2: Allopurinol - **Allopurinol prevents uric acid formation**, not myoglobin precipitation - Hyperuricemia is a *secondary* problem in rhabdo, not the primary cause of ATN - Allopurinol does **not** prevent tubular obstruction from myoglobin - This patient needs **immediate** myoglobin clearance, not long-term xanthine oxidase inhibition ### Option 3: Plasmapheresis - **Not standard** for rhabdo-induced ATN - Plasmapheresis is used for thrombotic microangiopathies (HUS, TTP), not rhabdomyolysis - **Aggressive hydration + alkalinization** is far more effective and is the standard of care - Plasmapheresis is invasive, time-consuming, and delays definitive therapy ## Clinical Pearl **Clinical Pearl:** In rhabdomyolysis-induced AKI, the **urine color** is a clinical guide: - **Dark brown/cola-colored urine** → myoglobin present, risk of ATN high - **Clear urine after hydration** → myoglobin cleared, recovery likely The target is to convert dark urine to clear urine within 6–12 hours through aggressive hydration and alkalinization. [cite:Harrison 21e Ch 297] ## High-Yield Facts **High-Yield:** The **critical difference** between standard ATN and rhabdo-ATN: - **Standard ATN** → Restore perfusion (fluids alone) - **Rhabdo-ATN** → Restore perfusion + alkalinize urine (fluids + bicarbonate) **Mnemonic — "MYOGLOBIN" Management:** - **M**assive IV fluids (target UOP > 200 mL/hr) - **Y**ou must alkalinize (sodium bicarbonate, target pH > 6.5) - **O**bserve urine color (dark = myoglobin, clear = recovery) - **G**lucose + insulin (for hyperkalemia if needed) - **L**oop diuretics (only if fluid overload develops) - **O**xidative stress (avoid NSAIDs, ACE inhibitors) - **B**icarbonate (3 amps in 1 L D5W, run at 1–1.5 mL/kg/hr) - **I**ntensive monitoring (K^+^, PO₄, Cr, urine pH q2–4h) - **N**ephrology consult (if no improvement in 24–48 hrs)